Kelly Paul Edward
SEC CIK 1658544 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS, INC. | Dir | 502.3K | $348.8K | $300.4K | 6 | 2022-01-03 | 2025-11-05 |
Most active insiders at RLMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shenouda Maged | CFO | $1.99M | — |
| 2 | TRAVERSA SERGIO | CEO, Dir | $1.54M | — |
| 3 | Ence Chuck | CAO, COO | $299.2K | — |
| 4 | Kelly Paul Edward | COO, Dir | $198.0K | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | 2025-11-05 | RLMD | RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | COO, Dir | P - Purchase | $2.20 | +90.0K | 502.3K | +22% | +$198.0K | |
| 2025-05-20 | 2025-05-16 | RLMD | RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | COO, Dir | P - Purchase | $0.43 | +200.0K | 412.3K | +94% | +$86.0K | |
| 2024-09-11 | 2024-09-09 | RLMD | RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | Dir | P - Purchase | $2.59 | +25.0K | 212.3K | +13% | +$64.8K | |
| D | 2022-04-05 | 2022-04-04 | RLMD | RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | Dir | S - Sale+OE | $30.04 | -10.0K | 187.3K | -5% | -$300.4K |
| D | 2022-04-05 | 2022-04-04 | RLMD | RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | Dir | M - OptEx | $3.24 | +10.0K | 197.3K | +5% | +$32.4K |
| D | 2022-01-05 | 2022-01-03 | RLMD | RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | Dir | M - OptEx | $3.24 | -20.0K | 187.3K | -10% | -$64.8K |
Purchase Sale Sale after option exercise All abbreviations